報價延遲最少15分鐘:2025/06/02 09:14 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
28.84/-0.86
|
|
企業價值
3.91M
|
| 資產負債 |
|
每股賬面淨值
1.06
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
9.78M
|
|
每股收益
2.61
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/02 09:14 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. |